Mobile

Study of the efficacy, safety and tolerability of repeated administration of eye drops containing regorafenib in newly diagnosed patients with "wet" or neovascular ("new blood vessel growth") Age-Rel...

Update Il y a 5 ans
Reference: EUCTR2012-003763-22

Study of the efficacy, safety and tolerability of repeated administration of eye drops containing regorafenib in newly diagnosed patients with "wet" or neovascular ("new blood vessel growth") Age-Related Macular Degeneration (wet AMD). Kombinovaná studie fáze IIa/IIb účinnosti, bezpečnosti a snášenlivosti opakovaných dávek očních kapek regorafenibu u dosud neléčených subjektů s věkem podmíněnou neovaskulární makulární degenerací

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Assess the effect of treatment with regorafenib eye drops on visual acuity at Study Week 4 and at Study Week 12 in subjects with subfoveal choroidal neovascularization due to age related macular degeneration. For Part B: in addition, explore an optimal dosing regimen

Inclusion criteria

  • Neovascular Age-related macular degeneration

Links